Ohio manufacturer nears deal for extraction technology
The Ohio-based PAO Group (PAOG) is one step closer to moving RespRX to market for the treatment of…
News April 26
Latest In: cannabis and COPD
Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD
A study out of St. Michael’s Hospital in Toronto has found prescription synthetic cannabinoids are linked to a…
News October 26Featured
1
Latest Sponsored
